Copyright
©The Author(s) 2022.
World J Clin Cases. Dec 16, 2022; 10(35): 13058-13063
Published online Dec 16, 2022. doi: 10.12998/wjcc.v10.i35.13058
Published online Dec 16, 2022. doi: 10.12998/wjcc.v10.i35.13058
Figure 1 Morphological observation of bone marrow cells (hematoxylin-eosin staining, magnification × 100).
A: Before chemotherapy; B: After induction therapy; C: After maintenance treatment; D: At first recurrence; E: After one cycle of venetoclax and azacytidine therapy; F: After one cycle of cytarabine, homoharringtonine and venetoclax therapy.
- Citation: Wang SL. Genetic changes in refractory relapsed acute myeloid leukemia with NPM1 mutation: A case report. World J Clin Cases 2022; 10(35): 13058-13063
- URL: https://www.wjgnet.com/2307-8960/full/v10/i35/13058.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i35.13058